Author:
Kwiecińska-Piróg Joanna,Bogiel Tomasz,Gospodarek Eugenia
Publisher
Springer Science and Business Media LLC
Subject
Drug Discovery,Pharmacology
Reference25 articles.
1. Endimiani, A. et al. Proteus mirabilis bloodstream infections: risk factors and treatment outcome related to the expression of extended-spectrum β-lactamases. Antimicrob. Agents Chemother. 49, 2598–2605 (2005).
2. O’Hara, C. M., Brenner, F. W. & Miller, J. M. Classification, identification and clinical significance of Proteus, Providencia and Morganella. Clin. Microbiol. Rev. 13, 534–546 (2000).
3. Champs, C., Bonnet, R., Sirot, D., Chanal, C. & Sirot, J. Clinical relevance of Proteus mirabilis in hospital patients: a two year survey. J. Antimicrob. Chemother. 45, 537–539 (2000).
4. Coker, C. h., Poore, C. A., Li, X. & Mobley, H. L. T. Pathogenesis of Proteus mirabilis urinary tract infection. Microb. Infect. 2, 1497–1505 (2000).
5. Różalski, A., Kwil, I., Torzewska, A., Baranowska, M. & Strączek, P. Proteus bacilli: features and virulence factors. Post. Hig. Med. Dośw. 61, 204–219 (2007).
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献